A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarction

Atherosclerosis

Volumn 128, Issue 1, 1997, Pages 107-112

  Brugada, Ramon ^a   Marian, A J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Coronary artery disease; Folic acid; Genetics; Homocysteine; Myocardial infarction; Risk factor

Indexed keywords

METHYLENETETRAHYDROFOLIC ACID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE MUTATION; GENOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR;

ALLELES; CORONARY DISEASE; FEMALE; GENOTYPE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MYOCARDIAL INFARCTION; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POINT MUTATION; POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 0031049530     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)05977-1     Document Type: Article

References (21)

1. Mayer EL, Jacobsen DW, Robinson K. Homocysteine and coronary atherosclerosis. JACC 1996;27:517-527.
2. Genest Jr JJ, McNamara JR, Salem DN, Wilson PWF, Schaefer EJ, Malinow MR. Plasma homocyst(e)ine levels in men with premature coronary artery disease. J Am Coll Cardiol 1990;16:1114-1119.
3. Robinson K, Mayer EL, Miller DP, Green R, van Lente F, Gupta A, Kottke-Marchant K, Savon SR, Selhub J, Nissen SE, Kunter M, Topol EJ, Jacobson DW. Hyperhomocysteinemia and low pyridoxal phosphate: Common and independent reversible risk factors for coronary artery disease. Circulation 1995;92:2825-2830.
4. Boers GHJ, Smals AGH, Trijbels FJM, Fowler B, Bakkeren JAJM, Schoonderwalt HC, Kleijer WJ, Kloppenborg PWC. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 1985;313:709-715.
5. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 1991;324:1149-1155.
6. Stampfer MJ, Malinow R, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Hennekens CH. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US Physicians. JAMA 1992;268:877-881.
7. Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The metabolic basis of inherited disease. New York: McGraw-Hill, 1989;693-734.
8. Daubner SC, Matthews RG. Purification and properties of methylenetetrahydrofolate reductase from pig liver. J Biol Chem 1982;257:140-145.
9. Goyette P, Summer JS, Milos R, Duncan AMV, Rosenblatt DS, Mathews RG, Rozen R. Human methylentetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nature Genetics 1994;7:195-200.
10. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Mathews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics 1995;10:111-113.
11. Goyette P, Frosst P, Rosenblatt DS, Rozen R. Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlation in severe methylenetetrahydrofolate reductase deficiency. Am J Hum Genet 1995;56:1052-1059.
12. Kang SS, Passen EL, Ruggie N, Wong PWK, Sora H. Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease. Circulation 1993;88:1463-1469.
13. Kang SS, Wong PWK, Susmano A, Sora J, Norusis M, Ruggie N. Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease. Am J Human Genet 1991;48:877-881.
14. Engbersen AMT, Franken DG, Boers GHJ, Stevens EMB, Trijbels FJM, Blom HJ. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 1995;56:142-150.
15. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;93:7-9.
16. Kluijtmans LAJ, van den Heuvel LPWJ, Boers GHJ, Frosst P, Stevens EMB, van Oost BA, den Heijer M, Trijbels FJM, Rozen R, Blom HJ. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996;58:35-41.
17. Puleo PR, Meyer D, Wathen C, Tawa CB, Wheeler S, Hamberg RJ, Ali N, Obermueller SD, Triana JF, Zimmerman JL, Perryman B, Roberts R. Use of rapid assay of subforms of creatine MB to diagnose or rule out acute myocardial infarction. N Engl J Med 1994;331:561-6.
18. Miller SA, Dykes DD, Polesky HF. A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
19. Rosenblatt DS. Inherited disorders of folate transport and metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (Eds). The metabolic basis of inherited disease. New York: McGraw-Hill, 1995;3111-3128.
20. Kang SS, Zhou J, Wong PWK, Kowalisan J, Strokosch G. Intermediate homocysteinemia: a thermolabile variant of methlenetetrahydrofolate reductase. Am J Hum Genet 1988;43:414-421.
21. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994;265:2037-2048.